Fusco, D., Malenica, I., Günthard, H. F., Gupta, S. K., Kurbegov, D., Balani, B., Olender, S., Aberg, J. A., Telep, L. E., Tian, Y., Blair, C., Wu, G., Haubrich, R. H., Wang, C.-Y., Chokkalingam, A. P., Osinusi, A. O., Wendtner, C.-M., & Gottlieb, R. L. (2024). Remdesivir for Treatment of COVID-19 Requiring Oxygen Support: A Cross-Study Comparison From 2 Large, Open-Label Studies. Clinical Infectious Diseases, 79(5), 1182–1189. https://doi.org/10.1093/cid/ciae336

Smith-Jeffcoat, S. E., Biddle, J. E., Talbot, H. K., Morrissey, K. G., Stockwell, M. S., Maldonado, Y., McLean, H. Q., Ellingson, K. D., Bowman, N. M., Asturias, E., Mellis, A. M., Johnson, S., Kirking, H. L., Rolfes, M. A. R., Olivo, V., Merrill, L., Battan-Wraith, S., Sano, E., McLaren, S. H., … Salvatore, P. P. (2023). Symptoms, Viral Loads, and Rebound Among COVID-19 Outpatients Treated With Nirmatrelvir/Ritonavir Compared With Propensity Score–Matched Untreated Individuals. Clinical Infectious Diseases, 78(5), 1175–1184. https://doi.org/10.1093/cid/ciad696

Mgbako, O., Mehta, M., Dietz, D., Neidell, M. J., Huang, S. (Esther), Zucker, J., Shoucri, S., Kubin, C. J., & Castor, D. (2023). Race and Remdesivir: Examination of Clinical Outcomes in a Racially and Ethnically Diverse Cohort in New York City. Ethnicity and Disease, 33(1), 1–8. https://doi.org/10.18865/1653

Laise, P., Stanifer, M. L., Bosker, G., Sun, X., Triana, S., Doldan, P., La Manna, F., De Menna, M., Realubit, R. B., Pampou, S., Karan, C., Alexandrov, T., Kruithof-de Julio, M., Califano, A., Boulant, S., & Alvarez, M. J. (2022). A model for network-based identification and pharmacological targeting of aberrant, replication-permissive transcriptional programs induced by viral infection. Communications Biology, 5(1). https://doi.org/10.1038/s42003-022-03663-8

Liu, H., Iketani, S., Zask, A., Khanizeman, N., Bednarova, E., Forouhar, F., Fowler, B., Hong, S. J., Mohri, H., Nair, M. S., Huang, Y., Tay, N. E. S., Lee, S., Karan, C., Resnick, S. J., Quinn, C., Li, W., Shion, H., Xia, X., … Stockwell, B. R. (2022). Development of optimized drug-like small molecule inhibitors of the SARS-CoV-2 3CL protease for treatment of COVID-19. Nature Communications, 13(1). https://doi.org/10.1038/s41467-022-29413-2

Hoffman, K. L., Schenck, E. J., Satlin, M. J., Whalen, W., Pan, D., Williams, N., & Díaz, I. (2022). Comparison of a Target Trial Emulation Framework vs Cox Regression to Estimate the Association of Corticosteroids With COVID-19 Mortality. JAMA Network Open, 5(10), e2234425. https://doi.org/10.1001/jamanetworkopen.2022.34425

Schultz, É., Atlani-Duault, L., Peretti-Watel, P., & Ward, J. K. (2022). Does the public know when a scientific controversy is over? Public perceptions of hydroxychloroquine in France between April 2020 and June 2021. Therapies, 77(5), 591–602. https://doi.org/10.1016/j.therap.2022.01.008

Lonze, B. E., Spiegler, P., Wesson, R. N., Alachkar, N., Petkova, E., Weldon, E. P., Dieter, R. A., Li, Y., Quinn, M., Mattoo, A., Soomro, I., Cohen, S. M., Leung, S., Deterville, C. L., Landrum, B. M., Ali, M. I., Cohen, D. J., Singer, A. L., Sen, A., … Montgomery, R. A. (2022). A Randomized Double-Blinded Placebo Controlled Trial of Clazakizumab for the Treatment of COVID-19 Pneumonia With Hyperinflammation*. Critical Care Medicine, 50(9), 1348–1359. https://doi.org/10.1097/ccm.0000000000005591

Sivapalasingam, S., Lederer, D. J., Bhore, R., Hajizadeh, N., Criner, G., Hosain, R., Mahmood, A., Giannelou, A., Somersan-Karakaya, S., O’Brien, M. P., Boyapati, A., Parrino, J., Musser, B. J., Labriola-Tompkins, E., Ramesh, D., Purcell, L. A., Gulabani, D., Kampman, W., Waldron, A., … Weinreich, D. M. (2022). Efficacy and Safety of Sarilumab in Hospitalized Patients With Coronavirus Disease 2019: A Randomized Clinical Trial. Clinical Infectious Diseases, 75(1), e380–e388. https://doi.org/10.1093/cid/ciac153

So, W., Simon, M. S., Choi, J. J., Wang, T. Z., Williams, S. C., Chua, J., & Kubin, C. J. (2022). Characteristics of procalcitonin in hospitalized COVID-19 patients and clinical outcomes of antibiotic use stratified by procalcitonin levels. Internal and Emergency Medicine, 17(5), 1405–1412. https://doi.org/10.1007/s11739-022-02955-5

Salerno, D. M., Jennings, D. L., Lange, N. W., Kovac, D. (Bley), Shertel, T., Chen, J. K., Hedvat, J., Scheffert, J., Brown Jr, R. S., & Pereira, M. R. (2022). Early clinical experience with nirmatrelvir/ritonavir for the treatment of COVID-19 in solid organ transplant recipients. American Journal of Transplantation, 22(8), 2083–2088. https://doi.org/10.1111/ajt.17027

Shah, N. J., Patel, V. G., Zhong, X., Pina, L., Hawley, J. E., Lin, E., Gartrell, B. A., Febles, V. A., Wise, D. R., Qin, Q., Mellgard, G., Joshi, H., Nauseef, J. T., Green, D. A., Vlachostergios, P. J., Kwon, D. H., Huang, F., Liaw, B., Tagawa, S., … Oh, W. K. (2022). The Impact of Androgen Deprivation Therapy on COVID-19 Illness in Men With Prostate Cancer. JNCI Cancer Spectrum, 6(3). https://doi.org/10.1093/jncics/pkac035

Criner, G. J., Lang, F. M., Gottlieb, R. L., Mathews, K. S., Wang, T. S., Rice, T. W., Madduri, D., Bellam, S., Jeanfreau, R., Case, A. H., Glassberg, M. K., Lyon, G. M., Ahmad, K., Mendelson, R., DiMaio, J. M., Tran, M. P., Spak, C. W., Abbasi, J. A., Davis, S. G., … Lowry, S. (2022). Anti-Granulocyte–Macrophage Colony–Stimulating Factor Monoclonal Antibody Gimsilumab for COVID-19 Pneumonia: A Randomized, Double-Blind, Placebo-controlled Trial. American Journal of Respiratory and Critical Care Medicine, 205(11), 1290–1299. https://doi.org/10.1164/rccm.202108-1859oc

Wolf, J., Abzug, M. J., Anosike, B. I., Vora, S. B., Waghmare, A., Sue, P. K., Olivero, R. M., Oliveira, C. R., James, S. H., Morton, T. H., Maron, G. M., Young, J. L., Orscheln, R. C., Schwenk, H. T., Bio, L. L., Willis, Z. I., Lloyd, E. C., Hersh, A. L., Huskins, C. W., … Nakamura, M. M. (2022). Updated Guidance on Use and Prioritization of Monoclonal Antibody Therapy for Treatment of COVID-19 in Adolescents. Journal of the Pediatric Infectious Diseases Society, 11(5), 177–185. https://doi.org/10.1093/jpids/piab124

Rodriguez, G. D., Wu, Y., Karnik, K., Ruddy, S., Kula, A., Warren, N., Yashayev, R., Sajid, F., Prasad, N., Yoon, J., Turett, G., Yung, L., Urban, C., Lee, C.-H., Abraham, J., Cooke, J. T., Sharma, M., Jaffer, A., & Segal-Maurer, S. (2022). Implementation of a Collaborated Antimicrobial Stewardship Program and Outpatient Parenteral Antimicrobial Therapy (OPAT) Unit-driven Monoclonal Antibody Therapy Program for COVID-19 at an NYC Hospital. International Journal of Infectious Diseases, 118, 214–219. https://doi.org/10.1016/j.ijid.2022.02.056

Driggin, E., Madhavan, M. V., & Gupta, A. (2022). The role of vitamin D in cardiovascular disease and COVID-19. Reviews in Endocrine and Metabolic Disorders, 23(2), 293–297. https://doi.org/10.1007/s11154-021-09674-w

Albuquerque, A. M., Tramujas, L., Sewanan, L. R., Williams, D. R., & Brophy, J. M. (2022). Mortality Rates Among Hospitalized Patients With COVID-19 Infection Treated With Tocilizumab and Corticosteroids. JAMA Network Open, 5(2), e220548. https://doi.org/10.1001/jamanetworkopen.2022.0548

Chiu, L., Lo, C.-H., Shen, M., Chiu, N., Aggarwal, R., Lee, J., Choi, Y.-G., Lam, H., Prsic, E. H., Chow, R., & Shin, H. J. (2021). Colchicine use in patients with COVID-19: A systematic review and meta-analysis. PLOS ONE, 16(12), e0261358. https://doi.org/10.1371/journal.pone.0261358